
New antiviral drugs to fight COVID-19 are on the way, with meetings held this week among NSW health officials to decide who will receive the medication.
Medical experts hope the two oral drugs - nirmatrelvir/ritonavir [brand name Paxlovid, made by Pfizer] and molnupiravir [brand name Lagevrio, made by Merck Sharpe and Dohme] - will save lives.